findmyKOL
Clinical trialNCT03132792CompletedPhase 1Interventional

AFPᶜ³³²T in Advanced HCC

SponsorAdaptimmuneEnrollment39AFP Expressing TumorsHepatocellular Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Paoli Calmettes Institute

    Marseille, France

  • Centre Eugène Marquis

    Rennes, France

  • Institute Gustave Roussy

    Villejuif, France

Spain
  • University Hospital of Barcelona

    Barcelona, Spain

  • University Hospital of Navarra

    Pamplona, Spain

United Kingdom
  • Beatson West of Scotland Cancer Centre

    Glasgow, United Kingdom

  • Guy'S Hospital

    London, United Kingdom

  • Nihr Uclh Clinical Research

    London, United Kingdom

  • the Christie Nhs Foundation Trust

    Manchester, United Kingdom

United States
  • Mayo Clinic Arizona

    Phoenix, Arizona, United States

  • Ucla

    Los Angeles, California, United States

  • Usc/norris Comprehensive Cancer Center

    Los Angeles, California, United States

  • University of Miami

    Miami, Florida, United States

  • Winship Cancer Institute - Emory University

    Atlanta, Georgia, United States

  • University of Maryland, Greenebaum Cancer Center

    Baltimore, Maryland, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • Mayo Clinic Clinical Trial Referral Office

    Rochester, Minnesota, United States

  • Washington University - School of Medicine

    St Louis, Missouri, United States

  • Md Anderson Cancer Center

    Houston, Texas, United States

  • Fred Hutchinson Cancer Research Centre

    Seattle, Washington, United States

  • Scca Immunotherapy Trials Intake

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
8 May 2017
Primary completion
7 Jul 2021
Completion
19 Nov 2025
Last update posted
17 Jun 2026
Registered enrollment
39
Registry id
NCT03132792

Cross-registrations

EU-CTR / CTIS (EudraCT)2017-000778-12

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.